198 related articles for article (PubMed ID: 24155236)
1. Functional consequences of complementarity-determining region deactivation in a multifunctional anti-nucleic acid antibody.
Lee J; Kim HJ; Roh J; Seo Y; Kim M; Jun HR; Pham CD; Kwon MH
J Biol Chem; 2013 Dec; 288(50):35877-85. PubMed ID: 24155236
[TBL] [Abstract][Full Text] [Related]
2. A Tat-grafted anti-nucleic acid antibody acquires nuclear-localization property and a preference for TAR RNA.
Jeong JG; Kim DS; Kim YS; Kwon MH
Biochem Biophys Res Commun; 2011 Mar; 406(3):403-7. PubMed ID: 21329654
[TBL] [Abstract][Full Text] [Related]
3. Heavy and light chain variable single domains of an anti-DNA binding antibody hydrolyze both double- and single-stranded DNAs without sequence specificity.
Kim YR; Kim JS; Lee SH; Lee WR; Sohn JN; Chung YC; Shim HK; Lee SC; Kwon MH; Kim YS
J Biol Chem; 2006 Jun; 281(22):15287-95. PubMed ID: 16551636
[TBL] [Abstract][Full Text] [Related]
4. Generation of a chickenized catalytic anti-nucleic acid antibody by complementarity-determining region grafting.
Roh J; Byun SJ; Seo Y; KIm M; Lee JH; Kim S; Lee Y; Lee KW; Kim JK; Kwon MH
Mol Immunol; 2015 Feb; 63(2):513-20. PubMed ID: 25458312
[TBL] [Abstract][Full Text] [Related]
5. Functional stability of 3D8 scFv, a nucleic acid-hydrolyzing single chain antibody, under different biochemical and physical conditions.
Lee J; Park H; Kim M; Seo Y; Lee Y; Byun SJ; Lee S; Kwon MH
Int J Pharm; 2015 Dec; 496(2):561-70. PubMed ID: 26536531
[TBL] [Abstract][Full Text] [Related]
6. Generation of humanized anti-DNA hydrolyzing catalytic antibodies by complementarity determining region grafting.
Kim DS; Lee SH; Kim JS; Lee SC; Kwon MH; Kim YS
Biochem Biophys Res Commun; 2009 Feb; 379(2):314-8. PubMed ID: 19103171
[TBL] [Abstract][Full Text] [Related]
7. A nucleic-acid hydrolyzing single chain antibody confers resistance to DNA virus infection in hela cells and C57BL/6 mice.
Lee G; Yu J; Cho S; Byun SJ; Kim DH; Lee TK; Kwon MH; Lee S
PLoS Pathog; 2014 Jun; 10(6):e1004208. PubMed ID: 24968358
[TBL] [Abstract][Full Text] [Related]
8. The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin.
Giles I; Lambrianides N; Latchman D; Chen P; Chukwuocha R; Isenberg D; Rahman A
Arthritis Res Ther; 2005; 7(1):R47-56. PubMed ID: 15642142
[TBL] [Abstract][Full Text] [Related]
9. De novo design of antibody complementarity determining regions binding a FLAG tetra-peptide.
Entzminger KC; Hyun JM; Pantazes RJ; Patterson-Orazem AC; Qerqez AN; Frye ZP; Hughes RA; Ellington AD; Lieberman RL; Maranas CD; Maynard JA
Sci Rep; 2017 Aug; 7(1):10295. PubMed ID: 28860479
[TBL] [Abstract][Full Text] [Related]
10. Construction of a scFv Library with Synthetic, Non-combinatorial CDR Diversity.
Bai X; Shim H
Methods Mol Biol; 2017; 1575():15-29. PubMed ID: 28255872
[TBL] [Abstract][Full Text] [Related]
11. Design and Generation of Humanized Single-chain Fv Derived from Mouse Hybridoma for Potential Targeting Application.
Khantasup K; Chantima W; Sangma C; Poomputsa K; Dharakul T
Monoclon Antib Immunodiagn Immunother; 2015 Dec; 34(6):404-17. PubMed ID: 26683180
[TBL] [Abstract][Full Text] [Related]
12. A Combination of Structural and Empirical Analyses Delineates the Key Contacts Mediating Stability and Affinity Increases in an Optimized Biotherapeutic Single-chain Fv (scFv).
Tu C; Terraube V; Tam AS; Stochaj W; Fennell BJ; Lin L; Stahl M; LaVallie ER; Somers W; Finlay WJ; Mosyak L; Bard J; Cunningham O
J Biol Chem; 2016 Jan; 291(3):1267-76. PubMed ID: 26515064
[TBL] [Abstract][Full Text] [Related]
13. Structural correlates of an anticarcinoma antibody: identification of specificity-determining residues (SDRs) and development of a minimally immunogenic antibody variant by retention of SDRs only.
Tamura M; Milenic DE; Iwahashi M; Padlan E; Schlom J; Kashmiri SV
J Immunol; 2000 Feb; 164(3):1432-41. PubMed ID: 10640759
[TBL] [Abstract][Full Text] [Related]
14. Arginine mutations in antibody complementarity-determining regions display context-dependent affinity/specificity trade-offs.
Tiller KE; Li L; Kumar S; Julian MC; Garde S; Tessier PM
J Biol Chem; 2017 Oct; 292(40):16638-16652. PubMed ID: 28778924
[TBL] [Abstract][Full Text] [Related]
15. Development of Lactobacillus paracasei harboring nucleic acid-hydrolyzing 3D8 scFv as a preventive probiotic against murine norovirus infection.
Hoang PM; Cho S; Kim KE; Byun SJ; Lee TK; Lee S
Appl Microbiol Biotechnol; 2015 Mar; 99(6):2793-803. PubMed ID: 25487889
[TBL] [Abstract][Full Text] [Related]
16. Production and characterization of an anti-idiotypic single chain Fv that recognizes an anti-DNA antibody.
Kwon MH; Lee MS; Kim KH; Park S; Shin HJ; Jang YJ; Kim HI
Immunol Invest; 2002; 31(3-4):205-18. PubMed ID: 12472180
[TBL] [Abstract][Full Text] [Related]
17. Cell- and nuclear-penetrating anti-dsDNA autoantibodies have multiple arginines in CDR3 of VH and increase cellular level of pERK and Bcl-2 in mesangial cells.
Im SR; Im SW; Chung HY; Pravinsagar P; Jang YJ
Mol Immunol; 2015 Oct; 67(2 Pt B):377-87. PubMed ID: 26189065
[TBL] [Abstract][Full Text] [Related]
18. Grafting of "abbreviated" complementarity-determining regions containing specificity-determining residues essential for ligand contact to engineer a less immunogenic humanized monoclonal antibody.
De Pascalis R; Iwahashi M; Tamura M; Padlan EA; Gonzales NR; Santos AD; Giuliano M; Schuck P; Schlom J; Kashmiri SV
J Immunol; 2002 Sep; 169(6):3076-84. PubMed ID: 12218124
[TBL] [Abstract][Full Text] [Related]
19. A germline knowledge based computational approach for determining antibody complementarity determining regions.
Zhao S; Lu J
Mol Immunol; 2010 Jan; 47(4):694-700. PubMed ID: 19939452
[TBL] [Abstract][Full Text] [Related]
20. Systematic classification of CDR-L3 in antibodies: implications of the light chain subtypes and the VL-VH interface.
Kuroda D; Shirai H; Kobori M; Nakamura H
Proteins; 2009 Apr; 75(1):139-46. PubMed ID: 18798566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
